Chunmei Shi

机构：Huazhong Agricultural University, National Cancer Institute, Center for Cancer Research · ORCID：0000-0002-0172-1729

发表论文 26 篇 · 总被引 633 次 · h-index 13

代表论文

• Results of a Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Trifluridine/Tipiracil (TAS-102) Monotherapy in Asian Patients With Previously Treated Metastatic Colorectal Cancer: The TERRA Study (2017 · Journal of Clinical Oncology · 被引 261)
• Molecular Profiles and Metastasis Markers in Chinese Patients with Gastric Carcinoma (2019 · Scientific Reports · 被引 55)
• Famitinib versus placebo in the treatment of refractory metastatic colorectal cancer: a multicenter, randomized, double-blinded, placebo-controlled, phase II clinical trial (2017 · 癌症：英文版 · 被引 44)
• sMicroRNA-1290 inhibits cells proliferation and migration by targeting FOXA1 in gastric cancer cells (2016 · Gene · 被引 39)
• Overexpression of FOXA1 inhibits cell proliferation and EMT of human gastric cancer AGS cells (2017 · Gene · 被引 33)
• A Comprehensive Survey of Genomic Alterations in Gastric Cancer Reveals Recurrent Neoantigens as Potential Therapeutic Targets (2019 · BioMed Research International · 被引 28)